Healthtech startup Practo is preparing for its initial public offering (IPO) with a significant pre-IPO fundraising round exceeding $100 million. The company’s projected EBITDA profitability in fiscal year 2025 and successful pilot in the United States are driving investor interest, potentially valuing Practo at $700 million. The upcoming IPO aims to leverage Practo’s fiscal discipline and focus on high-margin sustainability, fueled by global expansion initiatives.
Practo is aggressively scaling its software-as-a-service (SaaS) model globally, with its US operations already serving over 200,000 doctors and generating a $75 million gross merchandise value (GMV) run rate. Simultaneously, Practo is diversifying into physical infrastructure by establishing 40 co-branded dermatology clinics in India. These strategic moves position Practo as a strong player in the healthtech sector, with plans to tap into the public market soon.
Meanwhile, social media giant Meta, the parent company of WhatsApp, has committed to implementing a consent-based data-sharing framework for WhatsApp in compliance with the Competition Commission of India’s (CCI) directives by March 16. This development follows a legal battle dating back to 2024, where CCI found WhatsApp guilty of abusing its dominant position in India’s messaging market.
Source: Inc42 Media